scholarly article | Q13442814 |
P50 | author | Greg N. Fuller | Q37370656 |
P2093 | author name string | Wei Zhang | |
Dima Suki | |||
Ganesh Rao | |||
Yuhui Yang | |||
Daniel W Fults | |||
Tiffany Doucette | |||
P2860 | cites work | The Hallmarks of Cancer | Q221226 |
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. | Q48493738 | ||
Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas | Q48540461 | ||
Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors. | Q48564486 | ||
PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors. | Q48791387 | ||
What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator | Q48939992 | ||
Necrosis as a prognostic factor in glioblastoma multiforme | Q49057512 | ||
Expression of bcl-2 in small cell lung carcinoma cells. | Q54218040 | ||
Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death. | Q55473040 | ||
Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma. | Q55476546 | ||
A matter of life and death | Q63408384 | ||
BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma | Q73555358 | ||
Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system | Q81469233 | ||
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma | Q24670606 | ||
The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
Proliferation, cell cycle and apoptosis in cancer | Q28189476 | ||
Malignant astrocytic glioma: genetics, biology, and paths to treatment | Q29618156 | ||
The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations | Q30885944 | ||
AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer | Q33992717 | ||
Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation | Q34223630 | ||
Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis | Q34786608 | ||
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo | Q35080265 | ||
BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy | Q35454275 | ||
Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin | Q35763574 | ||
Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice | Q35801259 | ||
Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo | Q35829391 | ||
Insulin-like growth factor binding protein 2 promotes glioma development and progression | Q35880328 | ||
Platelet-derived growth factor (PDGF) and glial tumorigenesis | Q36247732 | ||
Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response | Q36416744 | ||
Bcl-2-family proteins and hematologic malignancies: history and future prospects | Q36508817 | ||
The prognostic influence of bcl-2 in malignant glioma | Q36644672 | ||
Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma | Q36825199 | ||
Bcl-2 family proteins and cancer | Q37310180 | ||
Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics | Q37761935 | ||
Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. | Q38302138 | ||
Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. | Q38351653 | ||
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins | Q39956386 | ||
Pharmacological inhibition of Bcl-2 family members reactivates TRAIL-induced apoptosis in malignant glioma | Q40070342 | ||
BCL-2-induced glioma cell invasiveness depends on furin-like proteases | Q40483596 | ||
Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis | Q40511321 | ||
Antisense-mediated inhibition of the bcl-2 gene induces apoptosis in human malignant glioma | Q40877693 | ||
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice | Q40881142 | ||
c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice | Q41589752 | ||
Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis | Q42827324 | ||
Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice | Q48148081 | ||
Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma | Q48200427 | ||
BCL-2 promotes migration and invasiveness of human glioma cells | Q48318360 | ||
BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study | Q48482815 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | oligodendroglioma | Q1318384 |
murine model | Q122890741 | ||
P304 | page(s) | 2093-2103 | |
P577 | publication date | 2011-03-04 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma | |
P478 | volume | 129 |
Q37706475 | Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma |
Q33589665 | Increased paired box transcription factor 8 has a survival function in glioma |
Q64108421 | Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) |
Q36179166 | Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma |
Q35091330 | Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis |
Q35827814 | Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice |
Q34062021 | Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas. |
Q51520445 | The protein expression profile of meningioma cells is associated with distinct cytogenetic tumour subgroups. |
Q26851645 | The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond |